Indian Pharma CDMOs Stand Strong Against Proposed US Tariffs: A Detailed Insight

Indian pharmaceutical CDMOs remain resilient against proposed US tariffs, leveraging global trends and maintaining a crucial role in the US generic drug supply chain. With signific...